托法替布治疗成人深在型环状肉芽肿1例

doi:10.35541/cjd.20230653

Chinese Journal of Dermatology ›› 2025, e20230653.doi: 10.35541/cjd.20230653

• Case Reports • Previous Articles Next Articles

Successful treatment of a case of deep granuloma annulare with tofacitinib

Meng Huijuan, Lin Qingxia, Zhang Dong, Ma Weiyuan

Department of Dermatology, Affiliated Hospital of Weifang Medical University, Weifang 261041, Shandong, China

Received:2023-11-10 Revised:2024-06-29 Online:2025-01-10 Published:2025-02-10
Contact: Ma Weiyuan E-mail:fymaweiyuan@wfmc.edu.cn
Supported by:
Affiliated Hospital of Weifang Medical University Scientific Research Project（2022BSQD07）

Abstract

CLC Number:

Meng Huijuan, Lin Qingxia, Zhang Dong, Ma Weiyuan. Successful treatment of a case of deep granuloma annulare with tofacitinib[J]. Chinese Journal of Dermatology,2025,e20230653. doi:10.35541/cjd.20230653

References ［7］

［1］	Wang YF, Geng Y, Xu XL. Generalized interstitial granuloma annulare with tuberculosis and cutis laxa: a rare case report. Int J Dermatol Venereol, 2023,6（3）:172⁃174. doi: 10.1097/JD9.000 0000000000060.
［2］	Lukács J, Schliemann S, Elsner P. Treatment of generalized granuloma annulare ⁃ a systematic review［J］. J Eur Acad Dermatol Venereol, 2015,29（8）:1467⁃1480. doi: 10.1111/jdv.12976.
［3］	Barbieri JS, Rosenbach M, Rodriguez O, et al. Association of granuloma annulare with type 2 diabetes, hyperlipidemia, autoimmune disorders, and hematologic malignant neoplasms［J］. JAMA Dermatol, 2021,157（7）:817⁃823. doi: 10.1001/jamadermatol.2021.1805.
［4］	Min MS, Wu J, He H, et al. Granuloma annulare skin profile shows activation of T⁃helper cell type 1, T⁃helper cell type 2, and Janus kinase pathways［J］. J Am Acad Dermatol, 2020,83（1）:63⁃70. doi: 10.1016/j.jaad.2019.12.028.
［5］	Damsky W, Thakral D, McGeary MK, et al. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare［J］. J Am Acad Dermatol, 2020,82（3）:612⁃621. doi: 10.1016/j.jaad.2019.05.098.
［6］	Wang A, Rahman NT, McGeary MK, et al. Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib［J］. J Allergy Clin Immunol, 2021,147（5）:1795⁃1809. doi: 10.1016/j.jaci.2020.10.012.
［7］	Damsky W, King BA. Treatment of granuloma annulare with tofacitinib 2% ointment［J］. JAAD Case Rep, 2020,6（1）:69⁃71. doi: 10.1016/j.jdcr.2019.10.016.

[1]	Chen Yanyan, Zhang Hanlin, Liu Liping, Li Yumei. Correlations between circadian rhythm and melanoma [J]. Chinese Journal of Dermatology, 2026, 59(1): 82-85.
[2]	Wang Xia, Xiang Jiyuan, Zeng Hengxi, Chen Xi, Liu Fuqian, Yang Bin. Mechanistic investigation into the inhibitory effect of CDK5 on melanin synthesis in melanocytes via a CDC42-MITF signaling pathway [J]. Chinese Journal of Dermatology, 2026, 59(1): 21-27.
[3]	Zhang Xiaoya, Xu Chenchen, Cui Bingnan. Anetoderma of Schweninger-buzzi type: a case report [J]. Chinese Journal of Dermatology, 2025, 58(12): 1186-1187.
[4]	Zhang Yude, Wang Hongjuan, Kang Xiaojing. Stem cell therapy for vitiligo: advances in basic and clinical research [J]. Chinese Journal of Dermatology, 2025, 58(9): 878-881.
[5]	Duan Bolin, Li Qianwen, Le Yue, Geng Mengmeng, Luo Longfei, Lei Tiechi. Rutin inhibits ultraviolet irradiation-induced dermal fibroblast senescence and melanogenesis in mouse ear skin [J]. Chinese Journal of Dermatology, 2025, 58(9): 801-807.
[6]	Xu Jingwei, Chen Shuang, Guo Kelei, Han Li, Bian Hua, . MicroRNAs regulating signaling pathways related to systemic scleroderma fibrosis [J]. Chinese Journal of Dermatology, 2025, 58(8): 788-793.
[7]	Lin Yangyang, Liu Xinxin, Song Yuantao, Zhao Li, Li Qinfeng. Generalized pustule psoriasis combined with PLEC gene variants in a child: a case report [J]. Chinese Journal of Dermatology, 2025, 58(6): 561-562.
[8]	Zhang Congcong, Chen Hao. Ferroptosis in melanoma [J]. Chinese Journal of Dermatology, 2025, 58(5): 481-484.
[9]	Jia Qian, Su Minjing, Zhuo Na, Li Xin, Han Jianwen. A case of epidermolysis bullosa simplex with mottled pigmentation and a family with localized epidermolysis bullosa simplex diagnosed by whole-exome sequencing [J]. Chinese Journal of Dermatology, 2025, 58(3): 260-262.
[10]	Hu Zixin, Tan Kexin, Dong Huijing, Zhang Xu, Yu Yixuan, Lu Xingyu, Li Jia, Cui Huijuan. Epidermal growth factor receptor inhibitor-related paronychia [J]. Chinese Journal of Dermatology, 2025, 58(3): 276-281.
[11]	Li Ming, Li Yan, Li Linfeng. JAK inhibitors for the treatment of moderate-to-severe atopic dermatitis [J]. Chinese Journal of Dermatology, 2025, 0(3): 20220342-e0220342.
[12]	Yu Peng, Wei Fenglei. Dupilumab treatment of atopic dermatitis with spontaneous regression of concurrent molluscum contagiosum: a case report [J]. Chinese Journal of Dermatology, 2025, 0(1): 20220841-e20220841.
[13]	Chen Yao, Dong Bilin, Zhang Xu, Chen Liuqing, Li Dongsheng, Tong Zhongsheng. Establishment of an athymic BALB/c mouse model with chronic infection due to Phialophora verrucosa [J]. Chinese Journal of Dermatology, 2017, 50(10): 724-728.

Successful treatment of a case of deep granuloma annulare with tofacitinib

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［7］

Related Articles 13

Metrics

Comments

Recommended 10